"We expect to introduce more than 25 innovative products into China between 2020 and 2025, covering immunity and inflammation, rare diseases and rare blood diseases, oncology, vaccines, cardiovascular and diabetes," Shi added.
施补充道：“我们预计在2020年至2025年期间将向中国引进超过25种创新产品，涵盖免疫和炎症、罕见病和罕见血液病、肿瘤学、疫苗、心血管和糖尿病。”。
The company established a global clinical data operations center in Chengdu, Sichuan province as early as 2018, and in 2021, it opened the Sanofi Institute for Biomedical Research in Suzhou, Jiangsu province — its first global research institute in China that focuses on cutting-edge biological research in major disease areas such as immunization and inflammation, oncology, rare diseases or rare blood disorders, neurology and diabetes.
该公司早在2018年就在四川省成都市建立了全球临床数据运营中心，并于2021年在江苏省苏州市开设了赛诺菲生物医学研究所，这是其在中国的第一家全球研究机构，专注于免疫与炎症、肿瘤学、，罕见病或罕见血液疾病、神经病学和糖尿病。
Jean-Christophe Pointeau, president of China Pfizer Biopharmaceutical Group, said that Cibinqo is the group's globally ground-breaking innovative product in inflammation and immunology, and a crucial part of its dermatology strategic planning in China.
中国辉瑞生物制药集团总裁Jean-Christophe Pointeau表示，Cibinqo是该集团在炎症和免疫学领域的全球突破性创新产品，也是其在中国皮肤科战略规划的重要组成部分。
Atopic dermatitis is a common chronic skin disease characterized by intense itching, skin inflammation and skin barrier defects.
特应性皮炎是一种常见的慢性皮肤病，以强烈瘙痒、皮肤炎症和皮肤屏障缺陷为特征。
Jean-Christophe Pointeau, president of Pfizer Biopharmaceutical Group China, said that these new products will cover the fields of oncology, vaccines, anti-infectives, inflammation and immunology, and rare disease areas.
辉瑞生物制药集团中国区总裁Jean-Christophe Pointeau表示，这些新产品将覆盖肿瘤学、疫苗、抗感染、炎症和免疫学以及罕见病领域。
In the recent years, through constant exploration, we have established an increasingly complete pipeline of innovative drugs in the inflammation and immunity field, covering diseases such as RA, ankylosing spondylitis, atopic dermatitis, and alopecia areata.
Located in the Suzhou Industrial Park, the research institute, which is the fourth of its kind by the company after the three in France, Germany and the United States respectively, will focus on early-stage research in the areas of oncology, immunology and inflammation, the company said.
The company said the medicine has benefited 23 million people with venous inflammation in many countries over the past 50 years.
Doctors said RA is an autoimmune disease that causes chronic joint inflammation and affects 5 million people in China.
US biotech company Amgen is aiming at rapid development of its business in China by bringing in more bone and inflammation therapies to build on its robust annual growth in the country.
The State Council Leading Group Office of Poverty Alleviation and Development, the National Health Commission and related departments launched a healthcare poverty alleviation project aimed at benefiting patients suffering from ankylosing spondylitis, a chronic disease that causes inflammation around the spinal vertebrae.
According to 3SBio, through the project patients can control inflammation, reduce pain, improve physical function and significantly improve their quality of life.
Representing an investment of 863 million yuan ($122 million), the innovation center focuses on research and early development of innovative drugs for immunology, inflammation and infectious diseases, and will further bring China's R&D to the world stage by developing innovative drugs to meet patients' unmet needs.
Another key area will be autoimmune diseases and inflammation, especially ulcerative colitis, Crohn's disease, chronic lung obstruction and severe asthma, and we hope to discover new targets and research directions.
The combined company will have nine products with more than $1 billion in annual sales, foreseeing significant potential for growth in oncology, immunology, and inflammation and cardiovascular disease.
Insilico has nominated eight preclinical drug candidates since 2021, which were discovered or designed using its proprietary AI platform in a variety of disease areas, including fibrosis, inflammation and cancer.
In the field of immunology, the company said it has eight clinical trials in different phases, covering illnesses such as Crohn's disease－an inflammation of the bowel－the skin disease psoriasis and lupus nephritis, a kidney condition brought on by the autoimmune disease lupus.
The new center is focused on the research and early development of innovative drugs for treating immunity, inflammation and anti-infectious diseases.
Representing an investment of 863 million yuan ($123.7 million), the innovation center focuses on research and early development of innovative drugs in areas of immunology and the treatment of inflammation and infectious diseases.
In the paper, the China Maternal and Child Health Association and UFH jointly asked postpartum rehabilitation facilities to achieve a set of goals, such as ensuring a more than 50 percent exclusive breastfeeding rate each month, conducting depression screening tests for new mothers every month, and reducing the incidence rate of mastitis — inflammation of the mammary gland — among new mothers and umbilical cord infection in newborns to less than 5 percent per month.